Brief: CASI Pharmaceuticals Says Partner Juventas Completed Series C Financing Of $63 Mln
25/10/2021 12:09
Oct 25 (Reuters) - CASI Pharmaceuticals Inc CASI.O :
* CASI PHARMACEUTICALS ANNOUNCES PARTNER JUVENTAS
COMPLETION OF
SERIES C FINANCING OF $63 MILLION (RMB410 MILLION) FOR
ACCELERATION OF CNCT19 PIVOTAL TRIALS AND COMMERCIALIZATION
Source text for Eikon: ID:nPnLq38Ya
Further company coverage: CASI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CASI Pharmaceuticals
See all newsBrief: Casi Pharmaceuticals Reports The Receipt Of Drug Registration Certificate For Thiotepa In China
CASI Pharmaceuticals Q3 revenue drops 60%, net loss widens
Brief: CASI Pharmaceuticals Inc Reports The Expiration Of Import Drug Registration License For Folotyn® In China
Casi Pharmaceuticals Inc Expected To Post A Loss Of 47 Cents A Share: Earnings Preview
Casi Pharmaceuticals Inc Reports Results For The Quarter Ended March 31: Earnings Summary